TickerFacts.

Vyome Holdings, Inc (HIND): Cost of Revenue

Annual figures by period end, from SEC filings.

$100.9K
Year ended 2025-12-31
-71.7%
3-year compound annual growth
-54.3%
5-year compound annual growth
-27.5%
10-year compound annual growth
$5.42M2014-12-31: $2.91M2015-12-31: $2.50M2016-12-31: $2.81M2017-12-31: $4.83M2018-12-31: $5.42M2019-12-31: $2.95M2020-12-31: $5.04M2021-12-31: $5.25M2022-12-31: $4.44M2023-12-31: $3.13M2024-12-31: $62.0K2025-12-31: $100.9K$100.9K
2014-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$100.9K+62.9%2026-03-18, From 2025-01-01
2024-12-31$62.0K-98.0%2026-03-18, From 2024-01-01
2023-12-31$3.13M-29.5%2025-04-04, From 2023-01-01
2022-12-31$4.44M-15.5%2024-04-01, From 2022-01-01
2021-12-31$5.25M+4.3%2023-04-17, From 2021-01-01
2020-12-31$5.04M+70.7%2022-04-08, From 2020-01-01
2019-12-31$2.95M-45.6%2021-03-12, From 2019-01-01
2018-12-31$5.42M+12.3%2020-02-27, From 2018-01-01
2017-12-31$4.83M+71.9%2019-02-22, From 2017-01-01
2016-12-31$2.81M+12.2%2018-03-05, From 2016-01-01
2015-12-31$2.50M-14.0%2018-03-05, From 2015-01-01
2014-12-31$2.91Mn/a2017-02-23, From 2014-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Vyome Holdings, Inc (HIND)2025-12-31$100.9K+62.9%
Abvc Biopharma, Inc. (ABVC)2024-12-31$763-99.7%
Scienture Holdings, Inc. (SCNX)2025-12-31$100.1K-23.4%
Clene Inc. (CLNN)2025-12-31$43.0K-38.6%
Quantum Cyber N.V. (QUCY)2025-12-31$147.3K-53.8%
Silence Therapeutics plc (SLN)2025-12-31$215.0K-98.2%
PMGC Holdings Inc. (ELAB)2025-12-31$404.8Kn/a
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$164.0K-92.3%
Polomar Health Services, Inc. (PMHS)2025-12-31$188.1K+573.8%

Compare HIND, ABVC, SCNX, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗